Your session is about to expire
← Back to Search
Behavioral Intervention
Activity Intervention for Pregnancy Stress (STEP Trial)
N/A
Waitlist Available
Led By Tracy A Manuck, MD
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Maternal age 18 to 51 years of age
Ability to communicate in and provide consent in English
Must not have
Women pregnant with multifetal gestations
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through reassessment of body composition at 16 weeks after randomization, an average of 4 months per participant.
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether a smartphone-based activity intervention using a wrist-based activity tracker can help high risk pregnant women reduce their stress during pregnancy.
Who is the study for?
This trial is for pregnant women at high risk of complications due to obesity or past issues like preeclampsia, with a stress score ≥14. They must be 8-19.9 weeks along in a single pregnancy without abnormalities, aged 18-51, speak English, and own a compatible smartphone.
What is being tested?
The study tests if using a wrist-based activity tracker and receiving enhanced counseling can reduce stress and improve outcomes during pregnancy compared to standard care. Participants will fill out questionnaires and provide blood samples for analysis.
What are the potential side effects?
There are no direct side effects from the intervention as it involves non-invasive tracking of activity levels. However, participants should consult their doctor if they have conditions that limit physical activity.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a woman aged between 18 and 51.
Select...
I can communicate and consent in English.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am pregnant with more than one baby.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through reassessment of body composition at 16 weeks after randomization, an average of 4 months per participant.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through reassessment of body composition at 16 weeks after randomization, an average of 4 months per participant.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Proportion of women with adverse perinatal outcomes
Reduction in Perceived Maternal Stress
Secondary study objectives
Gestational weight gain
Gestational weight gain, per week after study enrollment
Mean 'Moderate' or greater physical activity
+14 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Activity InterventionExperimental Treatment1 Intervention
Women randomized to this group will receive detailed information and reminders about physical activity and sleep in pregnancy. .
Group II: Usual careActive Control1 Intervention
Women randomized to this group will receive no guidance regarding exercise / activity / sleep during pregnancy.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Activity Intervention
2014
Completed Phase 2
~90
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for pregnancy complications include structured antepartum exercise programs and continuous fetal monitoring. Structured exercise programs help reduce the duration of labor stages and the need for medical interventions by improving physical fitness and reducing stress.
Continuous fetal monitoring ensures the well-being of the fetus during labor, allowing for timely medical interventions if necessary. These treatments are crucial as they promote a healthier, more natural labor process and reduce the risk of complications, thereby improving outcomes for both the mother and the baby.
Continuous fetal monitoring in the ambulant patient in labour.Effect of a structured antepartum exercise program on pregnancy and labor outcome in primiparas.Reanalysis of a multireported trial on home uterine activity monitoring.
Continuous fetal monitoring in the ambulant patient in labour.Effect of a structured antepartum exercise program on pregnancy and labor outcome in primiparas.Reanalysis of a multireported trial on home uterine activity monitoring.
Find a Location
Who is running the clinical trial?
University of North Carolina, Chapel HillLead Sponsor
1,554 Previous Clinical Trials
4,292,878 Total Patients Enrolled
6 Trials studying Pregnancy Complications
14,103 Patients Enrolled for Pregnancy Complications
Tracy A Manuck, MDPrincipal InvestigatorUniversity of North Carolina, Chapel Hill
1 Previous Clinical Trials
15 Total Patients Enrolled
1 Trials studying Pregnancy Complications
15 Patients Enrolled for Pregnancy Complications
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a woman aged between 18 and 51.I own a smartphone that works with a wrist activity tracker.I am pregnant with more than one baby.I can communicate and consent in English.
Research Study Groups:
This trial has the following groups:- Group 1: Activity Intervention
- Group 2: Usual care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger